Wenyan Qin

1.4k total citations
33 papers, 806 citations indexed

About

Wenyan Qin is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Wenyan Qin has authored 33 papers receiving a total of 806 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Cancer Research and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Wenyan Qin's work include Cancer-related molecular mechanisms research (8 papers), RNA modifications and cancer (5 papers) and MicroRNA in disease regulation (4 papers). Wenyan Qin is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), RNA modifications and cancer (5 papers) and MicroRNA in disease regulation (4 papers). Wenyan Qin collaborates with scholars based in China, United States and Saint Kitts and Nevis. Wenyan Qin's co-authors include Huizhe Wu, Xiao Hu, Minjie Wei, Qiuchen Chen, Yalun Li, Senxu Lu, Tong Sun, Xiufang Wang, Yuanhe Wang and Weifan Yao and has published in prestigious journals such as PLoS ONE, Oncogene and Scientific Reports.

In The Last Decade

Wenyan Qin

28 papers receiving 797 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenyan Qin China 13 661 519 51 51 50 33 806
Amanda Ferreira Vidal Brazil 18 530 0.8× 372 0.7× 46 0.9× 50 1.0× 63 1.3× 37 760
Junnan Liang China 13 583 0.9× 390 0.8× 78 1.5× 114 2.2× 35 0.7× 26 792
Lixian Zeng China 11 412 0.6× 224 0.4× 49 1.0× 64 1.3× 26 0.5× 18 552
Bing Wei China 15 408 0.6× 283 0.5× 77 1.5× 64 1.3× 25 0.5× 33 622
Bingyu Wang China 12 304 0.5× 220 0.4× 33 0.6× 26 0.5× 70 1.4× 31 487
Guangquan Xu China 8 495 0.7× 323 0.6× 82 1.6× 57 1.1× 34 0.7× 10 641
Xueying Yang China 15 474 0.7× 254 0.5× 54 1.1× 124 2.4× 42 0.8× 36 714
Lianhui Sun China 10 449 0.7× 193 0.4× 80 1.6× 94 1.8× 79 1.6× 14 690
Jiao Xue China 11 333 0.5× 142 0.3× 62 1.2× 83 1.6× 27 0.5× 24 519
Linlin Zhang China 16 425 0.6× 150 0.3× 71 1.4× 51 1.0× 51 1.0× 37 624

Countries citing papers authored by Wenyan Qin

Since Specialization
Citations

This map shows the geographic impact of Wenyan Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenyan Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenyan Qin more than expected).

Fields of papers citing papers by Wenyan Qin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenyan Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenyan Qin. The network helps show where Wenyan Qin may publish in the future.

Co-authorship network of co-authors of Wenyan Qin

This figure shows the co-authorship network connecting the top 25 collaborators of Wenyan Qin. A scholar is included among the top collaborators of Wenyan Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenyan Qin. Wenyan Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Yi, Yan Wang, Wenyan Qin, et al.. (2025). Pharmaceutical Design and Structure-activity Relationships of Psoralen and Derivatives. Current Pharmaceutical Design. 31(30). 2438–2463.
2.
Zhang, Qiaoli, et al.. (2025). Global research hotspots and trends of acupuncture regulating neuroplasticity: a bibliometric analysis from 2005 to 2024. Frontiers in Neurology. 16. 1615659–1615659.
3.
Du, Jianqiang, Wenyan Qin, Dan Zhao, et al.. (2025). Luteolin’s Potential in Managing Osteoporosis and Bone Metabolism Disorders: Preclinical Insights. Drug Design Development and Therapy. Volume 19. 9715–9732.
4.
Qin, Wenyan, Jianqiang Du, Feng Wang, & Junfeng Xu. (2025). Gastrodin: a potential natural product for the prevention and treatment of cerebral ischemia-reperfusion injury. Frontiers in Pharmacology. 16. 1554170–1554170. 1 indexed citations
5.
Du, Jianqiang, Wenyan Qin, Yandong Liu, et al.. (2025). Curculigoside is a Promising Osteoprotective Agent for Osteoporosis: Review. Drug Design Development and Therapy. Volume 19. 3323–3336. 1 indexed citations
6.
Wang, Jiaying, Qi Gao, Wenjuan Shen, et al.. (2024). Combined analysis of gut microbiota and metabolomics in high-fat model mice fed with Chlorella pyrenoidosa peptides. Journal of Functional Foods. 121. 106410–106410. 4 indexed citations
7.
Shou, L, et al.. (2024). Worldwide productivity and research trend of publications concerning intestinal polyps: A bibliometric study. Medicine. 103(2). e36507–e36507. 1 indexed citations
8.
Du, Ping, Wenyan Qin, Yiyi Hu, et al.. (2024). Intradermal acupuncture in the treatment of rheumatoid arthritis with liver and kidney deficiency syndrome – A sham-controlled, randomized, clinical trial. Complementary Therapies in Medicine. 82. 103037–103037. 3 indexed citations
9.
Ji, Pengyun, et al.. (2024). Vitamin D levels and its influencing factors in pregnant women in mainland China: A systematic review and meta-analysis. PLoS ONE. 19(5). e0297613–e0297613. 1 indexed citations
10.
Jiang, Yueting, et al.. (2023). Metagenomic next-generation sequencing of bronchoalveolar lavage fluid assists in the diagnosis of pathogens associated with lower respiratory tract infections in children. Frontiers in Cellular and Infection Microbiology. 13. 1220943–1220943. 5 indexed citations
11.
Wang, Xiufang, Zhikun Wu, Wenyan Qin, et al.. (2020). Long non-coding RNA ZFAS1 promotes colorectal cancer tumorigenesis and development through DDX21-POLR1B regulatory axis. Aging. 12(22). 22656–22687. 26 indexed citations
12.
Qin, Wenyan, et al.. (2020). Covered and Uncovered Self-Expandable Metallic Stents in the Treatment of Malignant Biliary Obstruction. Iranian Red Crescent Medical Journal. 22(7). 3 indexed citations
13.
Sun, Tong, Zhikun Wu, Xiufang Wang, et al.. (2020). LNC942 promoting METTL14-mediated m6A methylation in breast cancer cell proliferation and progression. Oncogene. 39(31). 5358–5372. 154 indexed citations
14.
Wu, Huizhe, Xiao Hu, Wenyan Qin, et al.. (2019). Associations of mRNA expression of DNA repair genes and genetic polymorphisms with cancer risk: a bioinformatics analysis and meta-analysis. Journal of Cancer. 10(16). 3593–3607. 12 indexed citations
15.
Qin, Wenyan, Xiaodong Wang, Yilin Wang, et al.. (2019). Functional polymorphisms of the lncRNA H19 promoter region contribute to the cancer risk and clinical outcomes in advanced colorectal cancer. Cancer Cell International. 19(1). 215–215. 13 indexed citations
17.
Zhang, Zhen, Qiuchen Chen, Jing Zhang, et al.. (2017). Associations of genetic polymorphisms in pTEN/AKT/mTOR signaling pathway genes with cancer risk: A meta-analysis in Asian population. Scientific Reports. 7(1). 17844–17844. 16 indexed citations
18.
Wei, Shijiao, Yimin Sun, Wenyan Qin, et al.. (2014). Systematic profiling of mRNA and miRNA expression in the pancreatic islets of spontaneously diabetic Goto-Kakizaki rats. Molecular Medicine Reports. 11(1). 67–74. 15 indexed citations
19.
Liu, Haiying, Yanzhi Yuan, Hongyan Guo, et al.. (2012). Hepatitis B Virus Encoded X Protein Suppresses Apoptosis by Inhibition of the Caspase-Independent Pathway. Journal of Proteome Research. 11(10). 4803–4813. 24 indexed citations
20.
Qin, Wenyan, et al.. (2006). A service relevance based matching algorithm on grid environment. Wuhan University Journal of Natural Sciences. 11(1). 269–272.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026